• Neurophth Raised Over $60 Million USD in Series-C Financing to Advance Gene Therapies

    11 days ago - By San Diego Biotechnology

    SAN DIEGO: SAN DIEGO, Nov. 23, 2021 /PRNewswire/ - Neurophth Therapeutics Ltd., , a fully integrated genomic medicines company dedicated on seeking to improve lives through the curative potential of gene therapies, today announced the closing of over $60 million USD in Series-C financing with a premier syndicate of investors,...
    Read more ...